SN

Satish Narayan Gunjikar

Active Director Managing Director DIN 00875383
DIN 00875383 First appointment Aug 1989 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 4 active board seats
Past companies 1 historical roles
Total affiliations 5 Since Aug 1989
Shareholding value •••• Premium profile

About Satish Narayan Gunjikar

Data last updated:

Satish Narayan Gunjikar is a Managing Director at Ar-Ex Laboratories Private Limited (since 1989), Managing Director at Bioxera Pharma Private Limited (since 2005) and Director at Bioxera Drugs Private Limited (since 2023), and holds 1 more current directorship. The companies operate in Pharma and Jewelry & Fashion Accessories. The 2 current companies with reported revenue have a combined latest revenue of ₹195 Cr; the largest is Ar-Ex Laboratories Private Limited at ₹115 Cr (FY 2025). Earlier, Satish Narayan Gunjikar was a Managing Director at Ar-Ex Chemicon Private Limited (from 1995).

DIN 00875383
Primary Designation Managing Director
Industry Pharma
First Appointment 01 Aug 1989
Oldest Company Age 70 yrs
Largest company Ar-Ex Laboratories Private Limited · ₹115 Cr (FY 2025)
Combined revenue ₹195 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Ar-Ex Laboratories Private Limited U24239MH1956PTC009736
Managing Director01 Aug 19891956₹115 Cr (FY 2025)Active
Bioxera Pharma Private Limited U24230MH2005PTC156737
Managing Director14 Oct 20052005₹79.20 Cr (FY 2025)Active
Bioxera Drugs Private Limited U86201MH2023PTC400444
Director11 Mar 2023
Ar-Ex Specialities Private Limited U33309MH2023PTC397992
Director20 Jan 20232023Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Ar-Ex Chemicon Private Limited U24100MH1974PTC017328
Managing Director13 Jun 19951974₹77,812 (FY 2017)Amalgamated

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Bioxera Drugs Private Limited
Ar-Ex Chemicon Private Limited
Bioxera Pharma Private Limited
Ar-Ex Laboratories Private Limited
Premium access

Shareholding and investment profile for Satish Narayan Gunjikar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Satish Narayan Gunjikar

Satish Narayan Gunjikar currently holds 4 directorships: Ar-Ex Laboratories Private Limited (Managing Director, since 01 Aug 1989, revenue ₹115 Cr (FY 2025)); Bioxera Pharma Private Limited (Managing Director, since 14 Oct 2005, revenue ₹79.20 Cr (FY 2025)); Bioxera Drugs Private Limited (Director, since 11 Mar 2023); Ar-Ex Specialities Private Limited (Director, since 20 Jan 2023).

Satish Narayan Gunjikar was first appointed on 01 Aug 1989 as Managing Director at Ar-Ex Laboratories Private Limited. The most recent appointment on record is 11 Mar 2023 at Bioxera Drugs Private Limited.

The 2 current companies of Satish Narayan Gunjikar that report revenue have a combined latest revenue of ₹195 Cr: Ar-Ex Laboratories Private Limited ₹115 Cr (FY 2025); Bioxera Pharma Private Limited ₹79.20 Cr (FY 2025).

Satish Narayan Gunjikar held 1 earlier board appointment: Ar-Ex Chemicon Private Limited (Managing Director, from 13 Jun 1995).

The current boards of Satish Narayan Gunjikar's companies include Ajit Narayan Gunjikar (Ar-Ex Laboratories Private Limited), Nitin Bhalchandra Mangaonkar (Ar-Ex Laboratories Private Limited), Sudha Narayan Gunjikar (Ar-Ex Laboratories Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available